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Abstract
Background: Vaginal self-sampling with HPV-DNA tests is a promising primary screening method for cervical cancer.
However, women’s experiences, concerns and the acceptability of such tests in low-resource settings remain unknown.
Methods: In India, Nicaragua, and Uganda, a mixed-method design was used to collect data from surveys (N = 3,863),
qualitative interviews (N = 72; 20 providers and 52 women) and focus groups (N = 30 women) on women’s and
providers’ experiences with self-sampling, women’s opinions of sampling at home, and their future needs.
Results: Among surveyed women, 90% provided a self- collected sample. Of these, 75% reported it was easy,
although 52% were initially concerned about hurting themselves and 24% were worried about not getting a
good sample. Most surveyed women preferred self-sampling (78%). However it was not clear if they responded to
the privacy of self-sampling or the convenience of avoiding a pelvic examination, or both. In follow-up interviews,
most women reported that they didn’t mind self-sampling, but many preferred to have a provider collect the vaginal
sample. Most women also preferred clinic-based screening (as opposed to home-based self-sampling), because the
sample could be collected by a provider, women could receive treatment if needed, and the clinic was sanitary
and provided privacy. Self-sampling acceptability was higher when providers prepared women through education,
allowed women to examine the collection brush, and were present during the self-collection process. Among survey
respondents, aids that would facilitate self-sampling in the future were: staff help (53%), additional images in the
illustrated instructions (31%), and a chance to practice beforehand with a doll/model (26%).
Conclusion: Self-and vaginal-sampling are widely acceptable among women in low-resource settings. Providers
have a unique opportunity to educate and prepare women for self-sampling and be flexible in accommodating
women’s preference for self-sampling.
Keywords: Self-sampling, Experiences, Cervical cancer screening, Human papillomavirus (HPV), Low income
resource settings
Background
Cervical cancer is largely preventable. However, it is the
third most common cancer among women worldwide,
and poses a public health problem in developing coun-
tries where 85% of the global deaths due to cervical
cancer occur [1]. Cervical cancer-related deaths have de-
creased significantly in developed countries due to wide-
spread screening based on Pap smear testing. However,
similar initiatives in developing countries have not had
the same success due to the complexity of the elements
required. The success of Pap smear testing depends on
repeat testing and high-quality laboratories, which drive
up costs [2]. Additionally, the lack of trained personnel
who can adequately read cytology samples leads to a
long waiting time (1 to 3 months) for receiving test re-
sults, causing high loss to follow-up [3].
As the sensitivity of speculum based Pap smears for
detecting moderate to severe cervical intraepithelial
neoplasia (CIN) or cancer has been shown to be sub-
optimal (50%) even in very high quality labs [4,5] the use of
HPV-DNA testing seems promising as a primary screening
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method in low-resource settings [6-9]. CareHPV™ is a new
HPV-DNA test that is ideal for low income resource set-
ting as it is cost-effective (lower cost per test) as compared
to other HPV-DNA tests, simple to use by laboratory tech-
nical staff and can provide rapid results within 3 hours [9].
CareHPV™ can be performed on both provider- and self-
collected samples, and findings show that the clinical
performance for detecting cervical intraepithelial neo-
plasia grade 2 or more severe diagnosis (CIN2+) was
comparable to other HPV-DNA screening tests such as
Hybrid Capture 2 [3,9].
Although recent studies have shown that provider-
collected cervical samples (collected during a pelvic
exam) resulted in the highest HPV-DNA sensitivity,
ranging between 84 and 100%, the sensitivity of self-
collected vaginal HPV-DNA tests ranged between 66
and 88%; both had similar specificities [10]. Moreover,
findings from recent systematic reviews show that self-
sampling was highly acceptable and that a majority of
women preferred vaginal self-sampling to provider-
collected cervical sampling [11,12]. As compared to the
conventional speculum based Pap smear procedure,
women preferred self-sampling because it was private,
comfortable, less painful, and less embarrassing [13,14].
Moreover, research indicates that the correlation be-
tween self-collected and provider-collected samples was
good [10,15]. In light of these results and given that self-
sampling does not require a pelvic exam with speculum,
it has the potential to be a more acceptable screening
option for women, especially in low-resource settings
where there are logistical limitations to performing the
exam, or in areas where there are cultural barriers to
conducting a pelvic exam [3].
Several studies have evaluated women’s opinions of
self-sampling [13,16-19]. However, to date, no studies
have provided a broad and in-depth examination of
women’s perspectives about self-sampling acceptability
especially in low-resource settings, using both quantita-
tive and qualitative research methods. Thus, the objec-
tives of this study were to gain further insight into:
1) women’s experiences and concerns with cervical can-
cer screening ; 2) women’s experiences and concerns with
self-sampling; 3) providers’ experiences of self-sampling;
4) women’s experiences with self-sampling at home; and
5) how to facilitate self-sampling in the future (e.g., guid-
ance in training or messaging).
Methods
This cross-sectional mixed-method study was imple-
mented within the context of a cervical cancer screen-
ing demonstration project, The Screening Technologies
to Advance Rapid Testing—Utility and Program Planning
(START-UP) project in India, Nicaragua, and Uganda,
the main objective of which was to generate evidence
comparing various screening options implemented by pub-
lic health systems in regionally representative developing-
country settings [20]. This study was conducted in
accordance with the Helsinki Declaration; study protocols
for each site were similar and were approved by local and
regional Institutional Review Boards in all project sites
(Nicaragua: Country IRB, Research Division - Minister of
Health; Uganda: Makerere University Ethics Committee;
India: Institute for Cytology and Preventive Oncology eth-
ics committee, MNJ Institute of Oncology and Regional
Cancer Center, Institute Ethics Committee), and by PATH’s
Research and Ethics Committee.
As part of the demonstration project, eligible women
that gave written consent were invited to self-collect a
vaginal careHPV™ (HPV-DNA) sample during their ini-
tial screening visit. If a woman chose not to self-sample,
a provider offered to collect the vaginal sample for
her. Subsequently, all enrolled women received a pelvic
examination (with speculum) during which a provider
collected a cervical careHPV™ sample and a cervical Pap
smear sample, and then performed visual screening with
acetic acid (VIA).
Quantitative study
Following these screening procedures, a pre-specified
20% random sample of women (if women refused to
participate, more were invited) from each site were in-
vited to participate in exit surveys. Verbal consent was
obtained from women who participated in the exit sur-
veys, and they were assured that refusal to answer any
question would not affect future follow-up or treatment
at the clinic. All of the exit surveys were conducted face
to face by women who were either health workers or
nurses in the study clinic. Survey participants were asked
closed-ended questions about their opinions, attitudes,
health-seeking behaviors, potential barriers related to cer-
vical cancer screening and self-collection procedures, and
about their experiences participating in the study. Respon-
dents were also asked if they collected a vaginal sample by
themselves. If they answered “yes,” they were asked add-
itional questions about their concerns (if any) of providing
such a sample, asked to rate how easy or difficult it had
been to collect the sample on a five-point Likert scale from
“very difficult” to “very easy” (they were further categorized
into “easy,” “neutral,” and “difficult”) and asked if they had
chosen to self-collect a vaginal sample or asked the pro-
vider to do so. Finally, all respondents were asked about
their opinions regarding additional aids needed to facilitate
self-collection of vaginal samples and whether they would
consider participating in future cervical cancer testing/
screening opportunities. All analyses were conducted using
Stata 12.0 (Statacorp, College Station, TX). Chi-square and
Fisher’s exact tests were used to test differences in propor-
tions between categories and study sites.
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Qualitative study
Preliminary analyses of the closed-ended exit surveys
revealed a need to gain greater understanding of the
acceptability and feasibility of women’s experiences with
self-sampling. As a result, a highly focused follow-up
study using qualitative research methods was designed.
Studies were conducted in India, Nicaragua, and Uganda.
In all three sites, semi-structured qualitative interviews
(SSIs) were conducted with the demonstration project
health providers and participants. In addition, in Nicaragua
and Uganda, the research teams organized focus group dis-
cussions (FGDs). All health providers involved in the dem-
onstration study participated in the SSIs; eligible women
returning to the clinic for further cervical cancer assess-
ment and/or treatment were opportunistically selected to
participate in SSIs and FGDs. Verbal consent was obtained
from all health providers and women that participated in
the SSIs and FGDs.
In all three sites, experienced qualitative research staff
conducted all of the SSIs and FGDs. During the follow-
up individual SSIs and FGDs, providers and women were
asked to describe reasons why women do not access
screening services, to describe in detail their personal
experiences with vaginal self-sampling, and whether they
preferred to collect a vaginal self-sample at home or in
the clinic and why or why not. In-depth notes were
taken during the SSIs and FGDs. Both the SSIs and the
FGDs were audio recorded so that the note-taker and
interviewer could refer to the recordings if they felt
that anything was missing from the notes or if they
had questions about the notes during analysis. All SSIs
and FGDs transcriptions were translated to English
and research teams in each country provided in-depth
session reports, and an overall summary report of their
impressions and insights after having completed all of
the SSIs and FGDs.
The in-depth session notes for SSIs and FGDs from
each site were independently analyzed by a qualitative
research specialist at PATH headquarters in the United
States. Common themes and/or issues were grouped to-
gether and frequencies were noted in order to highlight
key issues. These were shared and validated with local
research teams. As this was a qualitative study, the fre-
quencies were not reported. However, direct quotations
were pulled from the session reports when they were il-
lustrative of the issues.
Results
Among the total 19,340 eligible and completely screened
women from India, Nicaragua, and Uganda, 3,863 com-
pleted the exit survey, yielding an overall response rate
of 20.0%. The response rates varied by site: rural Uttar
Pradesh, India (18.7%); urban Hyderabad, India (22.3%);
Nicaragua (15.5%); and Uganda (19.3%). A total of 20
providers and 82 women enrolled in the study partici-
pated in the SSIs and FGDs (Table 1). Among these, 37
were from Hyderabad, 33 from Nicaragua, and 32 from
Uganda. Due to funding constraints, no components of
the qualitative study were conducted in Uttar Pradesh.
Women’s experience with self-sampling
In all four sites, nearly 90% of surveyed women re-
ported providing a self-collected vaginal sample (Figure 1).
This was the highest in Uganda (100%) and rural Uttar
Pradesh (99.5%), as compared to Nicaragua (82.8%) and
Hyderabad (78.6%).The following quotations from inter-
viewed providers in Uganda validate the observed high rate
there:
“Generally speaking, most of the women were more than
willing to do self-sampling. They were glad to do it and
to become involved in their own screening.” —Provider,
Uganda
“To me I think self-sampling is easily accepted as long
as women are provided with sufficient information
and they are given assurance about the safety of the
brush.” —Provider, Uganda
A project nurse explained the process undertaken to
prepare women for self-sampling in Uganda this way:
Study participants first attended a short talk, augmented
with a flipchart and/or video to illustrate the self-
sampling process. They were shown a sample careHPV™
collection brush and asked to feel how soft it was. Later,
women were taken to a private room where they were
given instructions on how to use the brush to obtain a
sample:
“I told them to insert the brush deep until it met
resistance, then I would tell them to rotate the brush 3
to 5 times.” —Provider, Uganda
Usually the provider would remain in the room, facing
away, in case they needed any additional help while
gathering the sample.
Ease and preference of self-sampling
More than half of surveyed respondents in each site re-
ported that it was relatively easy to take a self-collected
vaginal sample (p < 0.001) (Table 2). Women in rural
Uttar Pradesh (93.1%), Hyderabad (95.5%), and Uganda
(64.5%) preferred self-collected vaginal sampling, as com-
pared to provider-collected cervical-sampling (p < 0.001).
On the other hand, women in Nicaragua did not ap-
pear to have a preference: 50% preferred self-collected
vaginal sampling, and the other half preferred provider-
collected cervical-sampling. Regardless, women were
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positive about a screening test that did not involve a
speculum exam and, for the most part, were satisfied
with the experience, especially of having taken the sample
themselves:
“I did not have any difficulties inserting the brush. It is
painless, better than having a medical person tell you
to lie down on a bed, open your legs wide for visual
inspection.” —Study participant, Uganda
“The women who have done this test should tell about
their experiences to other women so that they may
come forward and do this test.” —Study participant,
India
Concern’s about self-sampling
Many surveyed women initially reported having con-
cerns with self-sampling (Table 2). Being worried about
hurting oneself was the principal concern among women
in Hyderabad (87.8%) and Nicaragua (65.1%), whereas
women in Uganda reported being most concerned about
not getting a good sample (47.4%) (p < 0.001); these were
the two most common worries in all sites. The following
quotations illustrate their experiences:
“I was worried that it might be painful, but there was
no pain at all.” —Study participant, India
“The women asked “did I do it well?” So I showed
them the secretions on the brush, and praised them for
doing a good job.” —Provider, Nicaragua
Additional concerns included unwillingness to touch
the genital region and/or the inability of women to see
their own genital area while doing the procedure.
“Rural women are more shy about touching themselves
than urban women, but will be more accepting of self-
sampling than urban women.” —Provider, Nicaragua
“Most women accepted self-sampling, but for those
who did not, the main reason they gave was not
wanting to touch themselves.” —Provider, Uganda
“To take the sample from that particular area is not
visible to me. I may not do it correctly, and may hurt
myself. I tried doing but could not do it.” —Study
participant, India
In India in particular, several respondents repeatedly
raised the issue of whether obese women would be
able to reach far enough to collect the vaginal sample
effectively.
Also, doubts with using the sample brush itself were
raised, as illustrated below:
“Some women were concerned about inserting the
brush too far into their vaginas and hurting
themselves.” —Provider, Nicaragua
“When they hear the word “brush,” women think of a
brush with stiff bristles like a toothbrush or scrub
brush. So I show them the sample brush. I let them
stroke their skin with it to feel how soft it is.” —Provider,
Uganda
Given these concerns, some interviewed respondents
expressed that they would prefer a provider to collect
the samples:
“I do not know where the small stick can go.” —Study
participant, Nicaragua
Table 1 Qualitative study participantsSSIs: semi-structured interviews; FGDs: focus group discussions
Participant SSIs Provider SSIs Participant FGDs Total respondents
Self-sampling ACCEPTORS Self-sampling REFUSERS # of sessions Total # of participants
Hyderabad 25 7 5 0 0 37
Nicaragua 5 5 10 2 13 33
Uganda 10 0* 5 2 17 32
*Very few START-UP study participants in Uganda refused self-sampling and no refusers returned to the clinic for follow-up and/or treatment during the qualitative
research period.
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“I prefer the medical person to do the sampling
because she will see where she is inserting.” —Study
participant, Uganda
“Everything was fine, but don’t want to do it by
myself.” —Study participant, India
Preference of self sampling at a clinic
Some interview respondents expressed feeling more
comfortable collecting the self-sample in a clinic than at
home, not only because providers could collect the sam-
ple and offer treatment, if needed, but also because the
clinics were clean and sanitary and provided privacy.
Also, to some, sampling at home seemed inconvenient:
“Doing it from home? I don’t know, I worry that it will
come back contaminated. I would prefer to have it done
in hospital because it takes such a short time. It does not
make much sense to take the kit home, take the sample
and then bring it back to hospital.” —Study participant,
Uganda
“May be disturbances when too many people are at
home. There is no time and privacy.” —Study
participant, India
“It would be best to let the woman do the self-sample
in the clinic the first time, then after she has experience,
she can do it at home in the future.” —Study participant,
Nicaragua
Furthermore, a number of providers shared these
opinions:
“The only problem that I see is the ability of these
women to take the specimen correctly even when the
information has been provided. Therefore, I would not
recommend for women to do this at home. I will
recommend that the specimen is collected at a health
facility. If there is need for privacy, you provide a room
for the woman to do the self-sampling. I do not think
they need to take the kit home—there is no need for
that.” —Study provider, Uganda
Reasons for not self-sampling
We also interviewed women who chose not to provide a
self-sample. Among survey participants, 399 (10.3%) of
women across all sites reported that they did not provide
a self-collected vaginal sample. When asked why they
had made that choice, 44.9% of these women were wor-
ried about hurting themselves, 23.1% expressed fear of
dropping the brush/equipment to collect the sample,
and 8.0% were concerned about not being able to take a
good sample (data not shown).
Survey participants were also asked whether they
had had concerns about participating in the overall
Table 2 Attitudes (concerns, ease, and preference) regarding self-sampling, among women who provided a self-collected
vaginal sample (number and percent)
All sites
(N = 3,464)
Rural Uttar Pradesh
(N = 937)
Hyderabad
(N = 912)
Nicaragua
(N = 704)
Uganda
(N = 911)
P value‡
Concerns about taking self vaginal sample*†
Hurting oneself 1,804 (55.1) 374 (40.0) 793 (87.8) 355 (65.1) 282 (31.5) <0.001
Not getting a good sample 822 (25.1) 154 (16.5) 79 (8.7) 165 (30.3) 424 (47.4) <0.001
Dropping the brush/equipment to collect the sample 138 (4.2) 24 (2.6) 49 (5.4) 3 (0.6) 62 (6.9) <0.001
Other 26 (0.8) 3 (0.3) 0 (0) 20 (3.7) 3 (0.3) <0.001
No concern 561 (17.1) 383 (41.0) 0 (0) 22 (4.0) 156 (17.4) <0.001
Ease of taking self vaginal sample
Easy 2,597 (75.0) 672 (71.7) 489 (53.6) 619 (88.3) 817 (89.7) <0.001
Neutral 704 (20.3) 260 (27.8) 300 (32.9) 53 (7.6) 91 (10.0)
Difficult 160 (4.6) 5 (0.5) 123 (13.5) 29 (4.1) 3 (0.3)
No response 3 (0.1) 0 (0) 0 (0) 3 (0.4) 0 (0)
Preferred collector of vaginal sample
Self 2,683 (77.5) 872 (93.1) 871 (95.5) 352 (50.0) 588 (64.5) <0.001
Provider 781 (22.5) 65 (6.9) 41 (4.5) 352 (50.0) 323 (35.5)
*Categories are not mutually exclusive; Women could select more than one response category.
†Percent’s are based on how many women answered the question; women that did not answer the question were excluded (All sites (N = 150); Rural Uttar Pradesh (N= 1);
Hyderabad (N= 0); Nicaragua (N = 149) and Uganda (N = 0)), and women that checked more than one response were accounted for (All sites (N = 37); Rural Uttar Pradesh
(N = 2); Hyderabad (N = 9); Nicaragua (N = 10) and Uganda (N = 16)), resulting in a sample size of: All sites (N = 3,277); Rural Uttar Pradesh (N = 934); Hyderabad (N = 903);
Nicaragua (N= 545) and Uganda (N = 895)).
‡P value comparing the distribution among study sites.
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demonstration study. Results show that the top three
primary concerns were: being afraid to find cancer or
pre-cancer (48.9%), being away from home or work
(28.2%), and not currently feeling sick or not having
any symptoms (26.5%) (Figure 2). When interviewed
respondents were asked why other women may not ac-
cess cervical cancer screening and treatment services,
they reported: fear of positive screening results, fear of
needing treatment, or fear of “losing part of the womb”
to a biopsy or surgery; lack of information about screen-
ing; fear of pain during screening or distaste for pelvic
exams due to the discomfort associated with the use of a
speculum; having to wait a long time for services or for re-
sults (especially for Pap smears) and the need for repeat
visits; refusal by husband or family elders to give permis-
sion to go to the clinic or be examined by a male provider;
and shyness or embarrassment about being examined by a
male provider.
Aids to facilitate self-sampling
When asked what could aid women to provide a self-
sample, 52.6% of all the women surveyed reported that
getting assistance with the procedure from staff would
be the primary aid needed, followed by more pictures
(30.6%), and use of a doll or model (25.9%) (Table 3).
Discussion
Among surveyed women in India, Nicaragua, and Uganda,
of the 90% that provided a self-collected sample for cer-
vical cancer screening, a vast majority preferred vaginal
sampling, whether done by themselves or a provider.
Given that these findings are consistent with previous re-
views, [11,12] self-sampling is a viable option for cervical
screening, especially in low-resource settings, and there-
fore can be incorporated into early detection programs to
increase coverage. These findings are particularly import-
ant given that screening women with an HPV-DNA test
once at 35 years of age has the potential to reduce the life-
time risk of cervical cancer by 36% [2]. This is especially
encouraging for clinics in developing countries with lim-
ited resources, as they can prioritize their efforts to effi-
ciently screen women and focus on treating those that test
positive.
The high rate of vaginal self-sampling that we observed
in this study, particularly in Uganda, illustrates that
providers have considerable influence on self-sampling.
Ugandan providers prepared women for self-sampling
through health education, allowing women to touch and
feel a sample brush, and were present to provide support
during the self-collection process. Once they realized that
some women imagined stiff hair brushes or toothbrushes
when they heard the word “brush” (and worried that such
a brush would hurt them), the staff began to emphasize
that it was a “soft brush.”
Even though we found that most interviewed women
were positive about vaginal self-sampling, many also
expressed that they would prefer a provider to collect
the vaginal sample rather than collecting it themselves.
This caused us to wonder what it was that attracted
women to the self-sampling option. Unfortunately we had
not incorporated probing questions to determine whether
women were most keen on the idea of taking the sample
themselves (for privacy) or whether they simply preferred
to not undergo a speculum exam and were happiest to
have someone else take the vaginal sample for them.
Given that the acceptability of pelvic examinations among
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Figure 2 Women’s concerns for participating in the overall demonstration study (N = 3863).
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women is low (51%) [15], that quite a few respondents
in the follow-up interviews mentioned concerns about
the quality of taking a sample themselves, and that
many women shared other, practical reasons why self-
sampling—especially away from the clinic—was prob-
lematic, it is tempting to speculate that vaginal sampling
was the draw. Further research into that question would
be useful. If that speculation is borne out, we can visualize
scenarios in which trained, female village health workers
or volunteers could be mobilized for mass sample collec-
tion. For example, a team of five or six experienced “vagi-
nal samplers,” given private spaces for each of them to
work in such as temporarily adapted school rooms, could
collect hundreds of samples in just a few hours without
the need for speculums or examination tables. This could
be a major factor in finally achieving screening at scale in
low-resource settings.
Our findings show that women were not inclined to-
ward vaginal self-sampling at home. Research in other
settings indicates mixed results. One study in China
found that a majority of women preferred to do self-
sampling at the clinic rather than at home [21]. A
study among Ugandan women from a low-resource
district in Kampala found that participation in a pro-
gram involving self-collection was positively associated
with health workers dropping off swabs at their homes
[18]. In South India, women had higher rates of par-
ticipation in self-sampling for cervical cancer screen-
ing at home (71.5%) than at the clinic (53.8%) [22].
In yet another study, women in Mexico preferred to
do the test in a clinic (76.8%) [23]. When asked why,
these women indicated that a provider could clarify
their questions, they felt more comfortable if a doctor/
nurse was present, and the provider could do the test if
needed.
As in other studies, many women in our study re-
ported challenges associated with vaginal self-sampling.
Women in our study reported their main concerns were
fear of pain and administering the test correctly; how-
ever, most of them did not report religious or cultural
barriers as hindering participation, as previously re-
ported [13,17-19,23]. Further barriers to screening were
expressed by women in our study as fear of finding out
that they had cancer, not feeling ill, and being away from
home or work. Similar results were found in an accept-
ability study in Mexico, where 70% reported lack of
symptoms and 61% of women reported lack of time as
major barriers to cervical cancer screening [23]. These
results highlight the continuing need for community
education and awareness outreach programs that dis-
pel fears/concerns and clarify misconceptions about
screening and that mobilize the entire community to en-
courage women to participate in cervical cancer screening
programs.
Our study had some limitations. First, aside from par-
ticipant age, socio-demographic information was not
collected. Hence, we were unable to assess the influence
of education, economic status, and other factors on the
acceptability of self-sampling or vaginal sampling. Sec-
ond, as our study was part of a larger demonstration
project, the women who participated in our study had
undergone four cervical cancer screening procedures,
and thus may not be representative of their respective
communities and/or countries. In addition, as sampling
for the survey, interviews and FGDs was opportunistic,
these findings should not be assumed to be generalizable
to larger populations. Furthermore, as participants for
interviews and FGDs were selected from women return-
ing to the clinic for further evaluation and/or treatment,
their views and opinions may not be representative of all
women and therefore should be interpreted with cau-
tion. These limitations notwithstanding, our findings do
address women’s experiences and concerns with cervical
cancer screening and provided valuable insights for vagi-
nal self-sampling acceptability and strategies, in low-
resource settings.
Table 3 Women’s opinions on future aids needed to facilitate self-collection of vaginal sample (number, percent)
All sites
(N* = 3,195)
Rural Uttar Pradesh
(N* = 917)
Hyderabad
(N* = 863)
Nicaragua
(N* = 705)
Uganda
(N* = 710)
P value‡
Aids needed to ease self-collection
in the future†
Staff help 1,679 (52.6) 479 (52.2) 496 (57.5) 311 (44.1) 393 (55.4) <0.001
More pictures 977 (30.6) 277 (30.2) 415 (48.1) 119 (16.9) 166 (23.4) <0.001
Doll/model 828 (25.9) 130 (14.2) 399 (46.2) 35 (5.0) 264 (37.2) <0.001
None 710 (22.2) 39 (4.3) 154 (17.8) 252 (35.7) 265 (37.3) <0.001
*Sample size’s are based on how many women answered the question; Of the total number of women ((All sites (N = 3,863); Rural Uttar Pradesh (N = 942);
Hyderabad (N = 1,160); Nicaragua (N = 850) and Uganda (N = 911)), women that did not answer the question were excluded (All sites (N = 181); Rural Uttar Pradesh
(N = 21); Hyderabad (N = 0); Nicaragua (N = 139) and Uganda (N = 21)), and women that checked more than one response were accounted for (All sites (N = 487);
Rural Uttar Pradesh (N = 4); Hyderabad (N = 297); Nicaragua (N = 6) and Uganda (N = 162)).
†Categories are not mutually exclusive; Women could select more than one response category.
‡P value comparing the distribution among study sites.
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Conclusion
In conclusion, despite the cultural diversity of women
in India, Nicaragua and Uganda, majority provided a
self- or provider-collected vaginal sample. In a future
study or during field implementation, we would rec-
ommend developing additional, culturally appropriate,
educational aids such as pictures, dolls, or models.
Because the language used to introduce the sample
collection device is key to women’s acceptance of self-
sampling, it is important to be sensitive in regards to
terminology used to describe the test (e.g., routinely
saying “soft brush” vs. “brush”). Further, future strat-
egies to promote vaginal-sampling for cervical cancer
screening programs could mobilize trained providers
to collect vaginal samples from women, or to support
women during self-sampling, assuming that a private
room can be provided in a clinic, health post, mobile
clinic, or temporary service site (such as a school). Fi-
nally, in order to increase the uptake of cervical screen-
ing, and because providers influence the acceptability
and success of vaginal self-sampling, it is imperative
that services consistently offer self-sampling and that
providers’ be comprehensive when presenting screening
options.
Competing interests
PB, SW, JLL, JLW, and PP have no competing interests. JJ was the director of
the demonstration study and received the careHPV tests as a donation from
the manufacturing company (QIAGEN).
Authors’ contributions
JJ and JLL participated in the design of the study and managed the conduct
of the study in all the sites. SW oversaw the design and data collection of
the qualitative data, analyzed and compiled the qualitative results. PB analyzed
and compiled the quantitative results and drafted the initial manuscript. All
authors made substantial contributions to the interpretation of the results and
assisted in drafting the manuscript. All authors read and approved the final
version of the manuscript.
Acknowledgments
The authors wish to thank the following researchers for administering the
qualitative interviews: Jessica Martinez Cruz, Nicaragua; Nirmala Devender
and Sujata Rao, India; and Elialilia Okello, Uganda. We also wish to thank the
following staff for their technical project support: Teah Hoopes, USA; Magda
Sequeira, Geovanni Alvarado, and Henry Espinoza, Nicaragua; Irfan Khan and
Usha Rani Poli, India; and Haawa Nakanwagi, Uganda. This project was
supported by a grant from the Bill & Melinda Gates Foundation.
Received: 29 August 2013 Accepted: 8 June 2014
Published: 12 June 2014
References
1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM: Estimates of
worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010,
127:2893–2917.
2. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C,
Wright TC, Alliance for Cervical Cancer Prevention Cost Working Group:
Cost-effectiveness of cervical-cancer screening in five developing countries.
N Engl J Med 2005, 353(20):2158–2168.
3. Sherris J, Wittet S, Kleine A, Sellors J, Luciani S, Sankaranarayanan R,
Barone MA: Evidence-based, alternative cervical cancer screening
approaches in low-resource settings. Int Perspect Sex Reprod Health
2009, 35(3):147–154.
4. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A,
Birembaut P, Kulasingam S, Sasieni P, Iftner T: Overview of the European
and North American studies on HPV testing in primary cervical cancer
screening. Int J Cancer 2006, 119(5):1095–1101.
5. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A,
Ratnam S, Coutlée F, Franco EL, Canadian Cervical Cancer Screening Trial
Study Group: Human papillomavirus DNA versus Papanicolaou screening
tests for cervical cancer. N Engl J Med 2007, 357(16):1579–1588.
6. Schiffman M, Wentzensen N: From human papillomavirus to cervical
cancer. Obstet Gynecol 2010, 116(1):177–185.
7. Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J,
Peto J, Ronco G, Sasieni P, Wheeler CM: Eurogin 2010 roadmap on
cervical cancer prevention. Int J Cancer 2011, 128(12):2765–2774.
8. Franco EL, Persistent HPV: Infection and cervical cancer risk: is the
scientific rationale for changing the screening paradigm enough? J Natl
Canc Inst 2010, 102(19):1451–1453.
9. Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH,
Peck RB, Li L, Chen F, Pan QJ, Lorincz AT: A new HPV-DNA test for
cervical-cancer screening in developing regions: a cross-sectional study
of clinical accuracy in rural China. Lancet Oncol 2008, 9:929–936.
10. Gravitt PE, Belinson JL, Salmeron J, Shah KV: Looking ahead: a case
for human papillomavirus testing of self-sampled vaginal specimens
as a cervical cancer screening strategy. Int J Cancer 2011,
129(3):517–527.
11. Huynh J, Howard M, Lytwyn A: Self-collection for vaginal human
papillomavirus testing: systematic review of studies asking women their
perceptions. J Low Genit Tract Dis 2010, 14(4):356–362.
12. Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T,
Mai V, HPV Self-collection Guidelines Panel: Self-collected samples for
testing of oncogenic human papillomavirus: a systematic review. J Obstet
Gynaecol Can 2007, 29(10):817–828.
13. Dzuba IG, Díaz EY, Allen B, Leonard YF, Lazcano Ponce EC, Shah KV,
Bishai D, Lorincz A, Ferris D, Turnbull B, Hernández Avila M, Salmerón J: The
acceptability of self-collected samples for HPV testing vs. the pap test as
alternatives in cervical cancer screening. J Womens Health Gend Based Med
2002, 11(3):265–275.
14. Quincy BL, Turbow DJ, Dabinett LN: Acceptability of self-collected human
papillomavirus specimens as a primary screen for cervical cancer. J Obstet
Gynaecol 2012, 32(1):87–91.
15. Safaeian M, Kiddugavu M, Gravitt PE, Ssekasanvu J, Murokora D, Sklar M,
Serwadda D, Wawer MJ, Shah KV, Gray R1: Comparability of self-collected
vaginal swabs and physician-collected cervical swabs for detection of
human papillomavirus infections in Rakai, Uganda. Sex Transm Dis 2007,
34(7):429–436.
16. Barbee L, Kobetz E, Menard J, Cook N, Blanco J, Barton B, Auguste P,
McKenzie N: Assessing the acceptability of self-sampling for HPV among
Haitian immigrant women: CBPR in action. Cancer Causes Control 2010,
21(3):421–431.
17. Forrest S, McCaffery K, Waller J, Desai M, Szarewski A, Cadman L, Wardle J:
Attitudes to self-sampling for HPV among Indian, Pakistani,
African-Caribbean and white British women in Manchester, UK.
J Med Screen 2004, 11(2):85–88.
18. Mitchell S, Ogilvie G, Steinberg M, Sekikubo M, Biryabarema C, Money D:
Assessing women’s willingness to collect their own cervical samples for
HPV testing as part of the ASPIRE cervical cancer screening project in
Uganda. Int J Gynaecol Obstet 2011, 114(2):111–115.
19. Howard M, Lytwyn A, Lohfeld L, Redwood-Campbell L, Fowler N, Karwalajtys T:
Barriers to acceptance of self-sampling for human papillomavirus
across ethnolinguistic groups of women. Can J Public Health 2009,
100(5):365–369.
20. Jeronimo J, Bansil P, Lim J, Peck R, Paul P, Amador JJ, Mirembe F,
Byamugisha J, Poli UR, Satyanarayana L, Asthana S, START-UP Study group:
A multi-country evaluation of careHPV™ testing, visual inspection with
acetic acid, and pap testing for the detection of cervical pre-cancer and
cancer. Int J Gynecol Cancer 2014, 24(3):576–585.
21. Tisci S, Shen YH, Fife D, Huang J, Goycoolea J, Ma CP, Belinson J, Huang RD,
Qiao YL: Patient acceptance of self-sampling for human papillomavirus
in rural china. J Low Genit Tract Dis 2003, 7(2):107–116.
22. Sowjanya AP, Paul P, Vedantham H, Ramakrishna G, Vidyadhari D,
Vijayaraghavan K, Laksmi S, Sudula M, Ronnett BM, Das M, Shah KV,
Gravitt PE, Community Access to Cervical Health Study Group:
Bansil et al. BMC Public Health 2014, 14:596 Page 8 of 9
http://www.biomedcentral.com/1471-2458/14/596
Suitability of self-collected vaginal samples for cervical cancer
screening in periurban villages in Andhra Pradesh, India. Cancer
Epidemiol Biomarkers Prev 2009, 18(5):1373–1378.
23. Arriba LN, Enerson CL, Belinson S, Novick L, Belinson J: Mexican cervical
cancer screening study II: acceptability of human papillomavirus
self-sampler. Int J Gynecol Cancer 2010, 20(8):1415–1423.
doi:10.1186/1471-2458-14-596
Cite this article as: Bansil et al.: Acceptability of self-collection sampling
for HPV-DNA testing in low-resource settings: a mixed methods
approach. BMC Public Health 2014 14:596.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bansil et al. BMC Public Health 2014, 14:596 Page 9 of 9
http://www.biomedcentral.com/1471-2458/14/596
